Global cancer immunotherapy sales share by type 2014 and 2021 forecast
This statistic depicts the global cancer immunotherapy sales distribution in 2014 and a projection for 2021, by type. Therapeutic vaccines made up some 15 percent of global cancer immunotherapy sales in 2014. This share is expected to decrease to around four percent by 2021.